You might also read
Articles linked to this work by shared authors, journal, and citation graph.
J Kusunose1, M K J Gagnon, J W Seo
1Department of Biomedical Engineering, University of California , Davis, CA , USA.
Researchers developed VCAM-1-targeted nanoparticles, including dendrimers and liposomes, for atherosclerosis. These nanocarriers showed specific binding to endothelial cells in microfluidic chambers under flow conditions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: